n-nitrosomorpholine has been researched along with pravastatin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; Iishi, H; Iseki, K; Nakaizumi, A; Tatsuta, M; Uehara, H; Yamamoto, R; Yano, H | 1 |
1 other study(ies) available for n-nitrosomorpholine and pravastatin
| Article | Year |
|---|---|
Suppression by pravastatin, an inhibitor of p21ras isoprenylation, of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
Topics: Animals; Anticarcinogenic Agents; Anticholesteremic Agents; Apoptosis; Blotting, Western; Carcinogens; Cholesterol; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Liver Neoplasms, Experimental; Male; Neoplasm Proteins; Nitrosamines; Pravastatin; ras Proteins; Rats; Rats, Sprague-Dawley | 1998 |